The remarkable success of Wellbeing International Foundation owes much to the vision and leadership of its Chairman, Max Lewinsohn. His personal journey with the foundation’s treatments has shaped his commitment to advancing regenerative medicine and making innovative therapies accessible to patients worldwide.
Lewinsohn first encountered the foundation’s work as a patient in 2010, seeking treatment for a knee damaged by sports injuries accumulated over many years. He became patient number 007 in what was then an experimental treatment programme, experiencing firsthand the transformative potential of cell-free therapy.
This personal experience profoundly influenced Lewinsohn’s subsequent involvement with the foundation. When the original Swiss company faced challenges in 2015, he led the acquisition of its intellectual property assets and continuing healthcare obligations through a private company. This decisive action protected the interests of existing patients and preserved the valuable research and protocols that had been developed.
In 2016, Lewinsohn established Wellbeing International Foundation Limited in Bermuda, creating a stable foundation for the organisation’s future growth. Under his leadership, the foundation has maintained a steadfast commitment to ethical practices, scientific rigour, and patient-centred care.
Lewinsohn’s vision extends beyond immediate clinical applications. He has consistently championed research and development, ensuring that the foundation continues to refine its protocols and explore new applications for cell-free therapy. This forward-thinking approach has positioned Wellbeing International Foundation at the cutting edge of regenerative medicine.
His leadership philosophy emphasises building a strong brand identity based on the highest ethical standards. Rather than pursuing rapid expansion, Lewinsohn has focused on establishing Wellbeing as the “gold standard” in cell-free therapy, with a reputation built on scientific evidence and patient outcomes rather than marketing claims.
This measured approach has proven effective in building Wellbeing’s reputation as a world leader in regenerative medicine. Through strategic partnerships with academic institutions and healthcare organisations, Lewinsohn has ensured that the foundation remains at the forefront of scientific innovation while maintaining its focus on transformative patient care.